Seeing Is Believing
Currently out of the existing stock ratings of Chris Lewis, 20 are a BUY (100%).
Analyst Chris Lewis, carries an average stock price target met ratio of 100% that have a potential upside of 21.45% achieved within 161 days. Previously, Chris Lewis worked at ROTH MKM, FIRST ANALYSIS.
Chris Lewis’s has documented 60 price targets and ratings displayed on 12 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CUTR, Cutera at 12-Sep-2017.
Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for GKOS (GLAUKOS CORP) at 4/14/2016. The price target of $24 was fulfilled within 20 days with a profit of $5.77 (31.65%) receiving and performance score of 15.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Feb-2025
$209
$65.26 (45.40%)
$200
2 months 26 days ago
(09-Jul-2026)
1/6 (16.67%)
$30.83 (17.30%)
99
Buy Since 18-Oct-2013
$210
$66.26 (46.10%)
4 months 10 days ago
(25-May-2026)
45/70 (64.29%)
$46.39 (28.35%)
147
Buy Since 04-Feb-2021
$220
$41.57 (23.30%)
$200
5 months 5 days ago
(30-Apr-2026)
8/19 (42.11%)
$43.99 (24.99%)
213
Hold Since 21-Oct-2025
$188
$9.57 (5.36%)
$169
5 months 11 days ago
(24-Apr-2026)
26/40 (65%)
$-1.61 (-0.85%)
128
Buy Since 01-May-2025
$235
$56.57 (31.70%)
$220
5 months 14 days ago
(21-Apr-2026)
18/53 (33.96%)
$39.8 (20.39%)
101